EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 28 September 2017

Revolutionising the fight against Alzheimer’s disease and mental illnesses (Guest blog)

A #WeWontRest guest blog

As the global population continues to age, the prevalence of conditions associated with old age has also risen. For Alzheimer’s disease, this means that there is an expected tripling of the burden of disease worldwide, and currently, there is no way to delay the disease’s progression. So while we live in the golden age of neuroscience – knowing more about the neurological system than ever before, there is more to be done, which is why I chose to make the development of new approaches in this area my first priority as the head of the Neuroscience Therapeutic Area at Janssen.

A guest blog by Husseini Manji, Global Head of the Neuroscience Therapeutic Area at Janssen Research & Development Read more

News

28092017 Destination EMA; making the right choice for patients
28 September 2017

As the decision on the future location for the European Medicines Agency (EMA) draws nearer, a new study from Charles... Read more

ARM, EBE, EFPIA and EuropaBio joint press release
27 September 2017

Read more

Blogs

28092017 Relvar Ellipta for COPD and Asthma Patients
28 September 2017

With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression,... Read more

28092017 EFPIA’s reflections on the PRAC’s First Public Hearing – a Route to Improved Healthcare...
28 September 2017 - Sini Eskola - Faraz Kermani

The enhanced focus on transparency has seen the EMA launch a revolutionary and potentially valuable tool, aimed at increasing... Read more

Events

15 June 2017 First edition of the ‘Real-World Evidence in Medicine Development’ course by GetReal...
02 October 2017 (Online learning)

A course by GetReal Read more

11 September 2017 2017 ICHOM Conference
25 October 2017 (Washington, D.C.)

Join value-innovators from across the health care spectrum in Washington, D.C. Read more

Certificate in Healthcare Compliance Ethics & Regulation
13 November 2017 (Paris, France)

The course presents European and International Laws in the Health and Life Sciences Sector to provide a thorough understanding... Read more

19 July 2017 War on Cancer – a patient’s journey
21 November 2017 (The HAC, London, UK)

3rd annual conference organised by The Economist Events Read more

What we are reading

Eduardo Bravo discusses the importance of pharmaceutical incentives to SMEs
On 25 September 2017 (The Parliament Magazine)

Incentives, particularly intellectual property (IP) protection, play a critical role in supporting EU SMEs like TiGenix... Read more

Research breakthroughs happen more easily when knowledge, data and resources are shared
On 25 September 2017 (The Parliament Magazine)

The history of medical research is filled with stories of individuals whose scientific breakthroughs have transformed... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu